AU2001290239A1 - Medicinal composition - Google Patents

Medicinal composition

Info

Publication number: AU2001290239A1
Authority: AU; Australia
Prior art keywords: medicinal composition; medicinal; composition
Prior art date: 2000-09-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001290239A

Inventor

Michiko Iketani

Hiroshi Kikuchi

Hideo Kobayashi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Daiichi Pharmaceutical Co Ltd

Original Assignee

Daiichi Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-19

Filing date

2001-09-19

Publication date

2002-04-02

2001-09-19 Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd

2002-04-02 Publication of AU2001290239A1 publication Critical patent/AU2001290239A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AU2001290239A 2000-09-19 2001-09-19 Medicinal composition Abandoned AU2001290239A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2000283565		2000-09-19
JP2000-283565		2000-09-19
PCT/JP2001/008137 WO2002024167A1 (en)	2000-09-19	2001-09-19	Medicinal composition

Publications (1)

Publication Number	Publication Date
AU2001290239A1 true AU2001290239A1 (en)	2002-04-02

Family

ID=18767909

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001290239A Abandoned AU2001290239A1 (en)	2000-09-19	2001-09-19	Medicinal composition

Country Status (11)

Country	Link
US (2)	US20040022848A1 (en)
EP (1)	EP1319399A1 (en)
JP (3)	JPWO2002024167A1 (en)
KR (1)	KR20030040389A (en)
CN (1)	CN1247188C (en)
AU (1)	AU2001290239A1 (en)
CA (1)	CA2419434A1 (en)
NO (1)	NO20031246D0 (en)
RU (1)	RU2281757C2 (en)
TW (1)	TWI290053B (en)
WO (1)	WO2002024167A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8101209B2 (en) *	2001-10-09	2012-01-24	Flamel Technologies	Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
CN100500130C (en) *	2003-01-23	2009-06-17	株式会社太平洋	Sustained-release preparations and method for producing the same
DE10323759A1 (en) *	2003-05-22	2004-12-16	Bauer, Wulf, Dr.	Remedies for internal use, especially against cancer
JP4808392B2 (en) *	2003-09-04	2011-11-02	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Pharmacological composition concealing bitterness
EP1825866A4 (en) *	2004-12-03	2008-03-12	Takeda Pharmaceutical	SOLID PREPARATION
US8524735B2 (en)	2005-05-18	2013-09-03	Mpex Pharmaceuticals, Inc.	Aerosolized fluoroquinolones and uses thereof
KR101538677B1 (en) *	2005-05-18	2015-07-22	엠펙스 파마슈티컬즈, 인코포레이티드	Aerosolized fluoroquinolones and uses thereof
US20070224323A1 (en) *	2006-03-23	2007-09-27	Fred Goldman	Sugar Replacement and Baked Goods and Caramels Using the Sugar Replacement
EP2118082B1 (en)	2007-02-23	2014-10-01	Gilead Sciences, Inc.	Modulators of pharmacokinetic properties of therapeutics
JP2011153075A (en) *	2008-04-04	2011-08-11	Shionogi & Co Ltd	Fine granule having improved suspension performance in water
EA022950B1 (en)	2008-05-02	2016-03-31	Джилид Сайэнс, Инк.	Use of silicon dioxide carrier particles to improve the processability of a pharmaceutical agent
CA2739897C (en)	2008-10-07	2017-10-03	Mpex Pharmaceuticals, Inc.	Aerosol fluoroquinolone formulations for improved pharmacokinetics
EP2346509B1 (en)	2008-10-07	2020-05-13	Horizon Orphan LLC	Inhalation of levofloxacin for reducing lung inflammation
RU2015130524A (en)	2009-09-04	2018-12-21	Раптор Фармасьютикалз Инк.	The use of levofloxacin in the form of an aerosol for the treatment of cystic fibrosis
JP2013032289A (en) *	2009-10-28	2013-02-14	Daiichi Sankyo Co Ltd	Wax stable formulation
US10842802B2 (en) *	2013-03-15	2020-11-24	Medicis Pharmaceutical Corporation	Controlled release pharmaceutical dosage forms
PT108978B (en) *	2015-11-24	2020-03-09	Hovione Farm S A	TETRACYCLINE SALTS
JP7672268B2 (en) *	2020-04-22	2025-05-07	沢井製薬株式会社	Coated particles containing solifenacin succinate and orally disintegrating tablets containing the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3130058B2 (en) *	1991-02-15	2001-01-31	第一製薬株式会社	Masked granules
JP2915590B2 (en) *	1991-02-15	1999-07-05	第一製薬株式会社	Masked granules
JP2915653B2 (en) *	1991-11-14	1999-07-05	第一製薬株式会社	Masked granules
JP3265680B2 (en) *	1992-03-12	2002-03-11	大正製薬株式会社	Oral pharmaceutical composition
EP0729748B1 (en) *	1993-11-18	2003-02-26	Nippon Shinyaku Company, Limited	Process for producing stable medicinal composition
KR100404293B1 (en) *	1995-05-02	2004-02-18	다이쇼 세이야꾸 가부시끼가이샤	Composition for Oral Administration
JPH0995439A (en) *	1995-09-29	1997-04-08	Eisai Co Ltd	Production of solid preparation
NZ332313A (en) *	1996-04-16	2000-02-28	Bayer Ag	D-mannitol and its preparation as a powder of not more than 1 square meter per gram
JP3126683B2 (en) *	1996-04-16	2001-01-22	武田薬品工業株式会社	D-mannitol and method for producing the same
US6235947B1 (en) *	1997-04-14	2001-05-22	Takeda Chemical Industries, Ltd.	D-mannitol and its preparation
IL128043A (en) *	1997-05-30	2004-08-31	Osmotica Corp	Multi-layered osmotic device for controlled delivery of active agents
AU3192700A (en) *	1999-03-17	2000-10-04	Daiichi Pharmaceutical Co., Ltd.	Medicinal compositions
US6383471B1 (en) *	1999-04-06	2002-05-07	Lipocine, Inc.	Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
JP2001270821A (en) *	2000-03-23	2001-10-02	Eisai Co Ltd	Powder powder with excellent feeling of taking
JP2001302497A (en) *	2000-04-21	2001-10-31	Eisai Co Ltd	Powdery preparation excellent in miscibility

2001
- 2001-09-19 US US10/380,160 patent/US20040022848A1/en not_active Abandoned
- 2001-09-19 TW TW090122999A patent/TWI290053B/en not_active IP Right Cessation
- 2001-09-19 RU RU2003111151/15A patent/RU2281757C2/en not_active IP Right Cessation
- 2001-09-19 CN CNB018155286A patent/CN1247188C/en not_active Expired - Fee Related
- 2001-09-19 KR KR10-2003-7001887A patent/KR20030040389A/en not_active Ceased
- 2001-09-19 JP JP2002528203A patent/JPWO2002024167A1/en not_active Withdrawn
- 2001-09-19 EP EP01970145A patent/EP1319399A1/en not_active Withdrawn
- 2001-09-19 CA CA002419434A patent/CA2419434A1/en not_active Abandoned
- 2001-09-19 AU AU2001290239A patent/AU2001290239A1/en not_active Abandoned
- 2001-09-19 WO PCT/JP2001/008137 patent/WO2002024167A1/en not_active Ceased
2003
- 2003-03-18 NO NO20031246A patent/NO20031246D0/en not_active Application Discontinuation
2007
- 2007-04-12 US US11/734,582 patent/US20070196504A1/en not_active Abandoned
2012
- 2012-05-24 JP JP2012118701A patent/JP2012158610A/en active Pending
2014
- 2014-03-10 JP JP2014046199A patent/JP2014132022A/en not_active Withdrawn

Also Published As

Publication number	Publication date
JPWO2002024167A1 (en)	2004-01-29
CA2419434A1 (en)	2003-02-07
JP2014132022A (en)	2014-07-17
NO20031246L (en)	2003-03-18
CN1455665A (en)	2003-11-12
JP2012158610A (en)	2012-08-23
EP1319399A1 (en)	2003-06-18
KR20030040389A (en)	2003-05-22
RU2281757C2 (en)	2006-08-20
NO20031246D0 (en)	2003-03-18
CN1247188C (en)	2006-03-29
US20040022848A1 (en)	2004-02-05
TWI290053B (en)	2007-11-21
US20070196504A1 (en)	2007-08-23
HK1057474A1 (en)	2004-04-08
WO2002024167A1 (en)	2002-03-28

Publication	Publication Date	Title
AU781269C (en)	2006-11-30	Pharmaceutical compositions
AU2001250420A1 (en)	2001-10-23	Pharmaceutical compositions
AU2001274307A1 (en)	2002-01-02	Pharmaceutical compositions
IL152659A0 (en)	2003-06-24	Pharmaceutical composition
AU2002313236A1 (en)	2003-05-15	Medicinal compositions
AU3192700A (en)	2000-10-04	Medicinal compositions
SI1524266T1 (en)	2007-08-31	Pharmaceutical composition
HUP0204555A3 (en)	2004-06-28	Pharmaceutical composition
AU2002258221A1 (en)	2003-05-08	Medicinal composition
AU2005300A (en)	2000-08-07	Medicinal compositions
AU1887401A (en)	2001-06-25	Medicinal composition
AU2002214324A1 (en)	2002-08-08	Medicinal compositions
AU2001290239A1 (en)	2002-04-02	Medicinal composition
AU2002221115A1 (en)	2002-06-24	Medicinal compositions having improved absorbability
IL154238A0 (en)	2003-09-17	Pharmaceutical composition
AU2001273919A1 (en)	2001-10-23	Pharmaceutical compositions
AU2001241098A1 (en)	2001-10-08	Composition
AU4085201A (en)	2001-09-24	Pharmaceutical composition
AU2001275201A1 (en)	2001-12-11	Acne-treating composition
AU2001287852A1 (en)	2002-03-26	Composition
AU2001267541A1 (en)	2001-12-11	Vaccine composition
AU3586401A (en)	2001-09-17	Pharmaceutical composition
AU2002354460A1 (en)	2003-07-09	Medicinal composition
AU2001287732A1 (en)	2002-04-08	Copolycarbonate-based composition
AU2001278788A1 (en)	2002-03-04	Oral composition